Editorial: quality versus quantity in myeloid infection by a herpesvirus: more than one way to skin the CCAAT?
Lukac
David M
DM
D022782:CCAAT-Enhancer-Binding Protein-beta / Q000037:antagonists & inhibitors*; D050684:E2F Transcription Factors / Q000037:antagonists & inhibitors; D015967:Gene Expression Regulation, Viral; D019288:Herpesvirus 8, Human / Q000235:genetics / Q000502:physiology*; D054884:Host-Pathogen Interactions; D006801:Humans; D016753:Interleukin-10 / Q000096:biosynthesis / Q000235:genetics; D015850:Interleukin-6 / Q000096:biosynthesis; D008264:Macrophages / Q000378:metabolism / Q000821:virology*; D035683:MicroRNAs / Q000502:physiology*; D018716:Molecular Mimicry; D014176:Protein Biosynthesis; D020033:Protein Isoforms / Q000037:antagonists & inhibitors; D012367:RNA, Viral / Q000235:genetics / Q000502:physiology*; D016160:Retinoblastoma Protein / Q000037:antagonists & inhibitors; D015533:Transcriptional Activation; D014764:Viral Proteins / Q000235:genetics / Q000502:physiology; D014779:Virus Replication
D022782:CCAAT-Enhancer-Binding Protein-beta; D050684:E2F Transcription Factors; C508609:IL10 protein, human; C508600:IL6 protein, human; D015850:Interleukin-6; D035683:MicroRNAs; D020033:Protein Isoforms; D012367:RNA, Viral; D016160:Retinoblastoma Protein; D014764:Viral Proteins; D016753:Interleukin-10